0000882104-15-000073.txt : 20151005
0000882104-15-000073.hdr.sgml : 20151005
20151005185457
ACCESSION NUMBER: 0000882104-15-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150929
FILED AS OF DATE: 20151005
DATE AS OF CHANGE: 20151005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stone Christopher Lewis
CENTRAL INDEX KEY: 0001453373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 151144719
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD.
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
4
1
wf-form4_144408568716877.xml
FORM 4
X0306
4
2015-09-29
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001453373
Stone Christopher Lewis
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
0
1
0
0
VP, Gen. Counsel & Secretary
Common stock
2015-09-29
4
A
0
15291
4.95
A
155764
D
The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2016; 16.66% on December 2017; 16.66% on December 2018; and 16.66% on December 2019.
/s/ Nathan N. Kryszak, Attorney-in-Fact for Christopher Lewis Stone
2015-10-05